TELA News and Press, TELA Bio Inc. From 10/21/20

MALVERN, Pa., Oct. 21, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, ann...

TELA Bio (TELA) has announced additional data from its BRAVO study with OviTex tissue matrix. Data were presented at the Americas Hernia Society Annual Meeting.30-day data from 85 subjects demonstrated that ventral hernia repair using OviTex resulted in low incidence of surgica...

MALVERN, Pa., Sept. 25, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that ...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Economic reports in the week ahead Tesla (NASDAQ:TSLA) will take top billing this week with its highly-anticipated Battery Day event ...

Volatility watch: Short interest has been in an uptrend for Vale (NYSE: VALE ) and Barrick Gold (NYSE: GOLD ) , while Tootsie Roll Industries (NYSE: TR ) and Signet Jewelers (NYSE: SIG ) stand out on the list of stocks with the highest percentage of short interest as total float. M...

MALVERN, Pa., Sept. 02, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced today that ...

The following slide deck was published by TELA Bio, Inc. in conjunction with this Read more ...

TELA Bio, Inc. (TELA) Q2 2020 Earnings Conference Call August 12, 2020 4:30 PM ET Company Participants Stuart Henderson - Vice President, Corporate Development & Investor Relations Tony Koblish - President & Chief Executive Officer Nora Brennan - Chief Financial Officer....

TELA Bio (NASDAQ: TELA ) : Q2 GAAP EPS of -$0.53 beats by $0.01 . More news on: TELA Bio, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

MALVERN, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today r...